FACACLASSIC

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”

HHS - 775 - Advisory Committee to the Director, National Institutes of Health - Authorized by Law

GENERAL INFORMATION

Committee Name	Advisory Committee to the Director, National Institutes of Health	Agency Name	Department of Health and Human Services
Fiscal Year	2025	Committee Number	775
Original Establishment Date	5/9/1966	Committee Status	Chartered
Actual Termination Date		Committee URL	http://acd.od.nih.gov/
Actual Merged Date		Presidential Appointments*	No
New Committee This FY	No	Max Number of Members*	21
Terminated This FY	No	Designated Fed Officer Position Title*	Principal Deputy Director, National Institutes of Health
Merged This FY		Designated Federal Officer Prefix
Current Charter Date	5/31/2023	Designated Federal Officer First Name*	Matthew
Date Of Renewal Charter	5/31/2025	Designated Federal Officer Middle Name	J.
Projected Termination Date		Designated Federal Officer Last Name*	Memoli
Exempt From Renewal*	No	Designated Federal Officer Suffix	M.D, M.S.
Specific Termination Authority		Designated Federal Officer Phone*	(301) 496-2433
Establishment Authority*	Authorized by Law	Designated Federal Officer Fax*	(301) 402-2700
Specific Establishment Authority*	42 USC 217a	Designated Federal Officer Email*	matthew.memoli@nih.gov
Effective Date Of Authority*	11/17/1962
Exempt From EO 13875 Discretionary Cmte	Not Applicable
Committee Type*	Continuing
Presidential*	No
Committee Function*	Scientific Technical Program Advisory Board

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*	Continue
Legislation to Terminate Required	Not Applicable
Legislation Status	Not Applicable
How does cmte accomplish its purpose?*	The Committee will advise, consult with, and make recommendations to the Secretary, the Assistant Secretary for Health, and the Director, NIH. The Committee will be held approximately three times within a fiscal year. Meetings will be open to the public except as determined by the Secretary at the request of the DFO in accordance with 5 U.S.C. 552b(c) and 41 C.F.R. 102-3.155 including specifying the specific exception(s) that justifies closure. Notice of all meetings will be given to the public. In the event a portion of a meeting is closed to the public, as determined by the Secretary, in accordance with the Government in the Sunshine Act (5 U.S.C. 552b(c)) and the Federal Advisory Committee Act, an annual report of closed or partially-closed meetings will be prepared which will contain, at a minimum, a list of members and their business addresses, the Committee’s functions, dates and places of meetings, and a summary of the Committee’s activities and recommendations made during the fiscal year.
How is membership balanced?*	The Committee will consist of the Secretary, or designee, as Chair, who will serve as a nonvoting ex-officio member, and up to 20 members appointed by the Secretary (appointed members). The appointed members will consist of authorities who are knowledgeable in the fields of research pertinent to the NIH mission and individuals selected from the academic and private sector research community, as well as individuals selected from the general public.
How frequent & relevant are cmte mtgs?*	During this reporting period the Committee convened once December 12-13, 2024
Why advice can't be obtained elsewhere?*	The members of the Advisory Committee to the Director have experience, current expertise, and abilities pertinent to the NIH mission that cannot be obtained from NIH staff or from other established sources.
Why close or partially close meetings?	There were no partially closed or closed meetings this FY.
Recommendation Remarks	Members: Currently, there are no members on the ACD. Membership was terminated on 5/27/2025 . There are 20 vacancies. Ex Officio Members: Dr. Bertagnolli's term ended 1/17/2025. Dr. Jay Bhattacharya, Director, NIH was appointed Ex Officio chair this fiscal year 04/01/2025. DFO/Committee Decision Maker: Based on the assignment of responsibilities within the Office of the Director, NIH, the positions of designated federal officer and the committee decision maker are held by the same person.

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*	Yes	Action Reorganize Priorities*	No
Outcome Trust In Government	No	Action Reallocate Resources	No
Outcome Major Policy Changes	No	Action Issued New Regulations	No
Outcome Advance In Scientific Research	Yes	Action Proposed Legislation	No
Outcome Effective Grant Making	Yes	Action Approved Grants Or Other Payments	No
Outcome Improved Service Delivery	No	Action Other	Yes
Outcome Increased Customer Satisfaction	No	Action Comment	The Advisory Committee to the Director, NIH, will provide advice to the Secretary of Health and Human Services (Secretary), the Assistant Secretary for Health, and the Director, National Institutes of Health (NIH), on matters related to planning, execution, conduct, support, and evaluation of biomedical research, medical science, and biomedical communications.
Outcome Implement Laws/Reg Requirements	No	Grants Review*	No
Outcome Other	No	Number Of Grants Reviewed	0
Outcome Comment	NA	Number Of Grants Recommended	0
Cost Savings*	Unable to Determine	Dollar Value Of Grants Recommended	$0.00
Cost Savings Comment	NIH supported basic and clinical research accomplishments often take many years to unfold into new diagnostic tests and new ways to treat and prevent diseases.	Grants Review Comment	NA
Number Of Recommendations*	0	Access Contact Designated Fed. Officer*	Yes
Number Of Recommendations Comment	Due to the complexity of the recommendations made by this committee on policy and program areas, staff is unable to determine which recommendations have been fully or partially implemented solely in response to this committee's activities.	Access Agency Website	Yes
% of Recs Fully Implemented*	0.00%	Access Committee Website	Yes
% of Recs Fully Implemented Comment	Due to the large breadth and complexity of the recommendations made by this committee, NIH staff is unable to determine which recommendations have been fully or partially implemented solely in response to this committee's activities.	Access GSA FACA Website	Yes
% of Recs Partially Implemented*	0.00%	Access Publications	No
% of Recs Partially Implemented Comment	NA	Access Other	Yes
Agency Feedback*	Yes	Access Comment	IC Committee Management Officer 240-276-6420
Agency Feedback Comment*	Information is provided to the public at each meeting. The public can view information related to the Committee through the committee’s official website.	Narrative Description*	NIH’s mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability. The Advisory Committee to the Director, NIH, advises the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, NIH, on matters related to planning, execution, conduct, support, and evaluation of biomedical research, medical science, and biomedical communications. The Advisory Committee to the Director has addressed numerous issues in these areas including: Diversity, Equity, Inclusion and Accessibility Initiatives; Researching COVID to Enhance Recovery Initiative; Advanced Research Projects Agency for Health (ARPA-H); Climate Change and Health; UNITE Initiative; Catalyzing the Development and Use of Novel Alternative Methods to Advance Biomedical Research; NIH Public Access Plan; Re-envisioning NIH-Supported Postdoctoral Training; Pandemic Preparedness and Response; Addressing Mental Health Crisis through Research; and Addressing the Public Health Threat of Post-Acute Sequelae of SARS-CoV-2 Infection.

COSTS

1. Payments to Non-Federal Members*	$2,200.00	1. Est Paymnts to Non-Fed Membrs Nxt FY*	$2,200.00
2. Payments to Federal Members*	$748.00	2. Est. Payments to Fed Members Next FY*	$748.00
3. Payments to Federal Staff*	$30,796.00	3. Estimated Payments to Federal Staff*	$0.00
4. Payments to Consultants*		4. Est. Payments to Consultants Next FY*
5. Travel Reimb. For Non-Federal Membrs*		5. Est Travel Reimb Non-Fed Membr nxtFY*
6. Travel Reimb. For Federal Members*		6. Est Travel Reimb For Fed Members*
7. Travel Reimb. For Federal Staff*		7. Est. Travel Reimb to Fed Staf Nxt FY*
8. Travel Reimb. For Consultants*		8. Est Travel Reimb to Consltnts Nxt FY*
10. Other Costs	$31,208.42	10. Est. Other Costs Next FY*	$31,520.00
11. Total Costs	$64,952.42	11. Est. Total Next FY*	$34,468.00
Date Cost Last Modified	9/17/2025 11:30 AM	Est. Fed Staff Support Next FY*	0.10
Federal Staff Support (FTE)*	0.10	Est Cost Remarks
Cost Remarks

Interest Areas

Category Area Health Public Health Medicine Health and Health Research

Custom Links

Committee Level Reports